Discipline | Infectious disease |
---|---|
Language | English |
Edited by | Roger Bedimo |
Publication details | |
History | 2014–present |
Publisher | Oxford University Press on behalf of the Infectious Diseases Society of America and HIV Medicine Association |
Frequency | Monthly |
Yes | |
License | Creative Commons or Government/Crown [1] |
4.423 (2021) | |
Standard abbreviations | |
ISO 4 | Open Forum Infect. Dis. |
Indexing | |
CODEN | OFIDA2 |
ISSN | 2328-8957 |
OCLC no. | 841980044 |
Links | |
Open Forum Infectious Diseases (OFID) is a peer-reviewed open-access scientific journal focusing on the field of infectious disease. It is operated by the Infectious Diseases Society of America (IDSA) and HIV Medicine Association and published online-only by Oxford University Press. [2]
The journal was launched in 2014 with infectious disease physician Paul Sax serving as editor-in-chief. [2] In 2023, Roger Bedimo, Chief of Infectious Diseases Section at the VA North Texas Health Care System and Professor of Medicine at the University of Texas Southwestern Medical Center in Dallas became editor-in-chief after Sax was appointed editor-in-chief of sister IDSA journal Clinical Infectious Diseases . [3] [4]
Initially organized in quarterly issues, the publication expanded to monthly issues in 2018. [5] [6] Since its inception, OFID has also published free podcast interviews with experts in the area of infectious disease. [7]
The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind. It is also the world's highest-impact academic journal. It was founded in England in 1823.
The Infectious Diseases Society of America (IDSA) is a medical association representing physicians, scientists, and other healthcare professionals who specialize in infectious diseases. It was founded in 1963 and is based in Arlington, Virginia. As of 2018, IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. It is a 501(c)(6) organization.
Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model. The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2021 impact factor of 50.129. The journal was established in January 1988. The founding editor was Josephine A. Morello. Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes was appointed editor-in-chief in 1997. Irving Nachamkin was appointed editor-in-chief in 2002 until 2012. Jo-Anne H. Young served as editor-in-chief from 2012 to 2022. The current editor-in-chief is Graeme Forrest. It is the ninth journal established and published by the American Society for Microbiology.
Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.
Peter Jay Hotez is an American scientist, pediatrician, and advocate in the fields of global health, vaccinology, and neglected tropical disease control. He serves as founding dean of the National School of Tropical Medicine, Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also Director of the Texas Children's Hospital Center for Vaccine Development and Endowed Chair in Tropical Pediatrics, and University Professor of Biology at Baylor College of Medicine.
Chronic Lyme disease (CLD) is the name used by some people with non-specific symptoms, such as fatigue, muscle pain, and cognitive dysfunction to refer to their condition, even if there is no evidence that they had Lyme disease. Both the label and the belief that these people's symptoms are caused by this particular infection are generally rejected by medical professionals. Chronic Lyme disease is distinct from post-treatment Lyme disease syndrome, a set of lingering symptoms which may persist after successful antibiotic treatment of infection with Lyme-causing Borrelia bacteria, and which may have similar symptoms to CLD.
Antimicrobial stewardship is the systematic effort to educate and persuade prescribers of antimicrobials to follow evidence-based prescribing, in order to stem antimicrobial overuse, and thus antimicrobial resistance. AMS has been an organized effort of specialists in infectious diseases, both in Internal Medicine and Pediatrics with their respective peer-organizations, hospital pharmacists, the public health community and their professional organizations since the late 1990s. It has first been implemented in hospitals. In the U.S., within the context of physicians' prescribing freedom, AMS had largely been voluntary self-regulation in the form of policies and appeals to adhere to a prescribing self-discipline until 2017, when the Joint Commission prescribed that hospitals should have an Antimicrobial Stewardship team, which was expanded to the outpatient setting in 2020.
David Arnold Relman is an American microbiologist and the Thomas C. and Joan M. Merigan Professor in Medicine, and in Microbiology & Immunology at the Stanford University School of Medicine. His research focuses on the human microbiome and microbial ecosystem—for which he was a pioneer in the use of modern molecular methods, as well as on pathogen discovery and the genomics of host response.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is a non-profit international organization with headquarters in Basel, Switzerland. Its mission is to improve the diagnosis, treatment, and prevention of infection-related diseases by promoting and supporting research, education, training, and good medical practice. An important activity of the society is the organization of the annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). This is recognized as the largest international forum for disseminating research in the fields of medical microbiology and infectious diseases for academic, clinical, and industry experts.
Dimitrios P. Kontoyiannis is the Robert C Hickey Chair in Clinical Care and Deputy Head for Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. He received his medical degree as valedictorian Summa Cum Laude from the National and Kapodistrian University of Athens, Greece. Kontoyiannis was trained in Internal Medicine at Baylor College of Medicine in Houston, where he served as a Chief Medical Resident. He was subsequently trained as a clinical fellow in Infectious Diseases at Massachusetts General Hospital and obtained a master's degree in Clinical Sciences from Harvard Medical School in Boston. He spent three years at the Whitehead Institute for Biomedical Sciences/Massachusetts Institute of Technology as a fellow in the Harvard MIT Clinical Investigators Training Program.
Céline R. Gounder is an American physician and medical journalist who specializes in infectious diseases and global health. She was a member of the COVID-19 Advisory Board transition team of then-incoming U.S. president Joe Biden. In 2022, she joined the Kaiser Family Foundation as senior fellow and editor-at-large for public health at Kaiser Health News.
The Society of Infectious Diseases Pharmacists (SIDP) is a non-profit association of pharmacists and other allied health professionals who specialize in infectious diseases and antimicrobial stewardship. According to the Board of Pharmaceutical Specialties, clinical pharmacists specializing in infectious diseases are trained in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials for patients.
Colleen S. Kraft is an infectious disease physician, associate professor in the Department of Pathology and Laboratory Medicine, and the director of the Clinical Virology Research Laboratory at Emory University School of Medicine. In 2014, she led Emory University Hospital's effort to treat and care for Ebola virus disease patients and is currently working to address the COVID-19 pandemic in Georgia. She currently serves on Georgia's COVID-19 task force.
Jasmine R. Marcelin is a Caribbean-American infectious disease physician and an Assistant Professor in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC). Marcelin is also the Associate Medical Director of the Antimicrobial Stewardship Program and as well as the Co-Director of Digital Innovation and Social Media Strategy at UNMC. Marcelin is dedicated to advancing diversity, inclusion, and equity in her communities and is a founding member of the Infectious Diseases Society of America Inclusion, Diversity, Access & Equity Taskforce. Marcelin uses social media to advance medicine, diversity, and patient advocacy and has published articles on how to effectively use social media for these purposes.
Rochelle Paula Walensky is an American physician-scientist who served as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023 and had also served as the administrator of the Agency for Toxic Substances and Disease Registry in her capacity as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023. On May 5, 2023, she announced her resignation, effective June 30, 2023. Prior to her appointment at the CDC, she had served as the chief of the Division of Infectious Diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School. Walensky is an expert on HIV/AIDS.
Daniel O’Connell Griffin is an American infectious disease specialist. He is president of the nonprofit organization Parasites Without Borders.
Sydney "Sid" Martin Finegold was an American physician, medical school professor, and medical researcher, specializing in anaerobic bacteriology.
Edward Harold Kass was an American physician, medical school professor, medical researcher in infectious diseases, medical journal editor, and historian of medicine. He is known for his research on toxic shock syndrome and urinary tract infections.
David Boulware is a professor of medicine and a practicing infectious disease physician at the University of Minnesota Medical School. He is a member of the graduate faculty for the University of Minnesota School of Public Health Epidemiology PhD program and for the Microbiology, Immunology, and Cancer Biology (MICaB) graduate program. Boulware was the first Lois & Richard King Distinguished Assistant Professorship at the University of Minnesota. Boulware is an active medical researcher engaged in clinical trials in infectious diseases. His expertise is particularly in the realm of HIV-related meningitis, including Cryptococcosis and Tuberculous_meningitis
Judith Aberg is an American physician who is the George Baehr Professor of Clinical Medicine at Mount Sinai Hospital. She was appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. Her research considered infectious diseases, including HIV/AIDS and COVID-19.